Genmab
GMAB
$30.40
Share price
2.29%
Change (1 day)
-33.17%
Change (1 year)
Categories
EPS for Genmab (GMAB)
EPS in 2023 (TTM): $1.53
According to Genmab's latest financial reports the company's current EPS (TTM) is $1.59. In 2022 the company made an earnings per share (EPS) of $1.84 an increase over its 2021 EPS that were of $1.13.
EPS history for Genmab from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.53 | -16.98% |
| 2022 | $1.84 | 62.07% |
| 2021 | $1.13 | -35.78% |
| 2020 | $1.77 | 119.14% |
| 2019 | $0.81 | 36.35% |
| 2018 | $0.59 | 29.83% |
| 2017 | $0.46 | 0.92% |
| 2016 | $0.45 | 47.69% |
| 2015 | $0.31 | 109.32% |
| 2014 | $0.15 | 134.03% |
| 2013 | $0.06238 | -121.08% |
| 2012 | -$0.30 | -23.69% |
| 2011 | -$0.39 | 94.77% |
| 2010 | -$0.20 | -70.48% |
| 2009 | -$0.67 |